https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53913 Wed 28 Feb 2024 15:58:52 AEDT ]]> Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:47056 Tue 13 Dec 2022 15:32:40 AEDT ]]>